The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives

被引:557
作者
Wanka, Lukas [1 ,2 ]
Iqbal, Khalid [2 ]
Schreiner, Peter R. [1 ]
机构
[1] Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany
[2] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA
关键词
METHYL-D-ASPARTATE; SYNTHETIC RETINOID CD437; DIPEPTIDYL-PEPTIDASE-IV; HEPATITIS-C VIRUS; M2 PROTON CHANNEL; SOLUBLE EPOXIDE HYDROLASE; NMDA RECEPTOR ANTAGONIST; INFLUENZA-A VIRUS; SMALL HETERODIMER PARTNER; OVARIAN-CARCINOMA CELLS;
D O I
10.1021/cr100264t
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The article reviews concentrates on the numerous applications in medicinal chemistry and drug development of adamantane derivatives. The aminoadamantanes are synthetic drugs that have not been inspired by natural products like numerous other drugs. There are, however, also isolates from Nature incorporating an adamantane motif, like 'nature's marvel,' tetrodotoxin. Like amantadine, it also blocks an ion channel, the sodium channel. This potent pharmaceutical activity may be, at least in part, attributed to its rigid dioxaadamantane core. The mutations, in turn, destabilize the closed channel, making it easier to open, which counters the effect of the aminoadamantanes. This model could be advantageous for drug design, because drugs that are larger than hydrated ions do have to overcome a higher energetic barrier to find a binding site inside a pore than to bind to the channel complex from the membrane-facing outside.
引用
收藏
页码:3516 / 3604
页数:89
相关论文
共 886 条
  • [81] BROWN SY, 1990, DRUG METAB DISPOS, V18, P546
  • [82] Identification of novel ligands for the gabapentin binding site on the α2δ subunit of a calcium channel and their evaluation as anticonvulsant agents
    Bryans, JS
    Davies, N
    Gee, NS
    Dissanayake, VUK
    Ratcliffe, GS
    Horwell, DC
    Kneen, CO
    Morrell, AI
    Oles, RJ
    O'Toole, JC
    Perkins, GM
    Singh, L
    Suman-Chauhan, N
    O'Neill, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1838 - 1845
  • [83] Crystal structures of dipeptides containing the Dmt-Tic pharmacophore
    Bryant, SD
    George, C
    Flippen-Anderson, JL
    Deschamps, JR
    Salvadori, S
    Balboni, G
    Guerrini, R
    Lazarus, LH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) : 5506 - 5513
  • [84] DIFFERENTIAL BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF COMPETITIVE AND NONCOMPETITIVE NMDA RECEPTOR ANTAGONISTS IN RATS
    BUBSER, M
    KESEBERG, U
    NOTZ, PK
    SCHMIDT, WJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (01) : 75 - 82
  • [85] Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted Imidazoles as potent cholecystokinin-2 (CCK2) antagonists
    Buck, IM
    Black, JW
    Cooke, T
    Dunstone, DJ
    Gaffen, JD
    Griffin, EP
    Harper, EA
    Hull, RAD
    Kalindjian, SB
    Lilley, EJ
    Linney, ID
    Low, CMR
    McDonald, IM
    Pether, MJ
    Roberts, SP
    Shankley, NP
    Shaxted, ME
    Steel, KIM
    Sykes, DA
    Tozer, MJ
    Watt, GF
    Walker, MK
    Wright, L
    Wright, PT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) : 6803 - 6812
  • [86] A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through σ1 receptors
    Bucolo, C
    Marrazzo, A
    Ronsisvalle, S
    Ronsisvalle, G
    Cuzzocrea, S
    Mazzon, E
    Caputi, A
    Drago, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (1-2) : 200 - 203
  • [87] Selective blockade of Ca2+ permeable AMPA receptors in CA1 area of rat hippocampus
    Buldakova, S. L.
    Kim, K. K.
    Tikhonov, D. B.
    Magazanik, L. G.
    [J]. NEUROSCIENCE, 2007, 144 (01) : 88 - 99
  • [88] Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel blocking drug, IEM-1460
    Buldakova, SL
    Vorobjev, VS
    Sharonova, IN
    Samoilova, MV
    Magazanik, LG
    [J]. BRAIN RESEARCH, 1999, 846 (01) : 52 - 58
  • [89] Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats
    Burkey, BF
    Li, X
    Bolognese, L
    Balkan, B
    Mone, M
    Russell, M
    Hughes, TE
    Wang, PR
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02) : 688 - 695
  • [90] Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents
    Burstein, ME
    Serbin, AV
    Khakhulina, TV
    Alymova, IV
    Stotskaya, LL
    Bogdan, OP
    Manukchina, EE
    Jdanov, VV
    Sharova, NK
    Bukrinskaya, AG
    [J]. ANTIVIRAL RESEARCH, 1999, 41 (03) : 135 - 144